New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...

Discover the best gummy vitamins recommended by dietitians and what to look for when choosing a high-quality supplement you’ll actually enjoy.

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Researchers from Skoltech, MEPhI, and the Dukhov All-Russian Research Institute of Automation have proposed a new method to ...

Heat-resilient biofertilizers could help crops cope with rising temperatures but engineering them has been slow and uncertain ...

Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline ...

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.

We're only days away from the much-anticipated return of the "Gamma" Air Jordan 11. The style was originally introduced in 2013, and this month it's coming back to shelves as part of Jordan Brand's ...